Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
national blog main
san diego blog main
3
×
san diego top stories
clinical trials
fda
national top stories
san diego
san francisco blog main
acute myeloid leukemia
adverum biotechnologies
alder biopharmaceuticals
ambit biosciences
amgen
athena countouriotis
bial
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brett zbar
bristol-myers squibb
calcitonin gene-related peptide
chronic migraine
cormorant asset management
daiichi sankyo
david rind
detroit blog main
detroit top stories
drug development
eli lilly
episodic migraine
eptinezumab
erenumab
food and drug administration
fremanezumab
galcanezumab
halozyme therapeutics
hbm healthcare investments
What
gets
3
×
drug
fda
new
nod
add
amgen
approval
athena
biotech
called
cancer
candidates
carbidopa
ceo
chief
class
combination
control
countouriotis
daily
developed
disease
experience
financing
head
levodopa
medical
medication
medicines
mezzanine
migraine
million
names
neurocrine
officer
old
pain
parkinson’s
patients
Language
unset
Current search:
gets
×
biotech
×
" san diego blog main "
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
